• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

13
2
2
2

COUNTRY

2

CATEGORIES

  • 11
  • 8
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
4
7
27

PUBLISHED

0
0
5
27

PRODUCT TYPE

26
1

Search "Calypte Biomedical Corporation" returned 27 results.

PRODUCT TITLE

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis Summary Calypte Biomedical Corporation (Calypte) is a diagnostic company. It carries out the development, manufacture and marketing...

April 2012
FROM
Calypte Biomedical Corporation Deals and Alliances Profile Calypte Biomedical Corporation Deals and Alliances Profile - Product Thumbnail Image

Calypte Biomedical Corporation Deals and Alliances Profile

Calypte Biomedical Corporation Deals and Alliances Profile Introduction Global Market Direct’s Calypte Biomedical Corporation Deals and Alliances Profile is an essential source for company data...

June 2007
FROM
Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape - Product Thumbnail Image

Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape

Diagnostic practice is undergoing a quiet revolution, with IVD tests moving out of the centralized hospital laboratory to point of care testing (POCT) locations POC tests are more expensive than lab-based...

January 2010
FROM

Point of Care Diagnostic Testing Sector Trends

Point of care testing enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days...

November 2011
FROM
The Top 100 Point-Of-Care Manufacturing Companies Worldwide (2nd Edition) The Top 100 Point-Of-Care Manufacturing Companies Worldwide (2nd Edition) - Product Thumbnail Image

The Top 100 Point-Of-Care Manufacturing Companies Worldwide (2nd Edition)

According to Christopher P Price, Visiting Professor, Clinical Biochemistry, University of Oxford, ‘The purpose of point of care testing is the provision of a test result at the most appropriate point...

May 2009
FROM
HIV/AIDS Testing - Global Strategic Business Report HIV/AIDS Testing - Global Strategic Business Report - Product Thumbnail Image

HIV/AIDS Testing - Global Strategic Business Report

This report analyzes the worldwide markets for HIV/AIDS Testing in US$ Million by the following product segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests....

October 2010
FROM

United States In Vitro Diagnostics Market Outlook to 2016

United States In Vitro Diagnostics Market Outlook to 2016 Summary Our new report, “US In Vitro Diagnostics Market Outlook to 2016” provides key market data on the US In Vitro Diagnostics (IVD) market....

July 2010
FROM

Point of Care Diagnostic Testing World Markets

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or...

May 2014
FROM

Over-the-Counter Diagnostic Products World Markets

The purpose of this TriMark Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets It examines the diagnostic...

October 2012
FROM
United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to the USA In vitro...

September 2009
FROM

High-Growth Diagnostic Testing Markets

There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also...

November 2013
FROM
Biotechnology Reagents - Global Strategic Business Report Biotechnology Reagents - Global Strategic Business Report - Product Thumbnail Image

Biotechnology Reagents - Global Strategic Business Report

This report analyzes the worldwide markets for Biotechnology Reagents in US$ Million by the following Product Segments: Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis...

April 2012
FROM

Lateral Flow Technology and the Future of Point of Care Diagnostics

Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that...

February 2007
FROM

Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There...

November 2006
FROM

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready?...

November 2009
FROM

Key Diagnostic Testing Markets

This report reviews the high-growth market segments for clinical laboratory testing equipment and supplies in the clinical hospital market, using screening reagents and instruments for analysis of individual...

December 2004
FROM

The World Market for Immunoassays

The immunoassay market is large and long-established, but at the same time highly competitive The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting...

November 2013
FROM

The Worldwide Market for In Vitro Diagnostic Tests - 3rd Edition

This comprehensive report is a thorough overview of the in vitro diagnostics (IVD) industry worldwide, covering the breadth of traditional IVD testing (Kalorama released a report dedicated to the molecular...

April 2002
FROM

HIV: Markets for Diagnostics and Therapeutics

The strategic concept of HIV/AIDS diagnosis and therapy is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS diagnostics...

October 2008
FROM

The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

This completely updated edition of Kalorama’s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all...

April 2006
FROM
Loading Indicator